- Docket No.
- 1:22-cv-02604
- District Court
- District of Columbia
Goal
- Invalidate all or part of a federal regulation
- Stop the government from enforcing the statute or regulation
Issues
Litigation Content
Why this Matters:
The plaintiffs allege that a federal regulation allowing insurers and pharmacy benefit managers to not apply financial support from a drug manufacturer towards a patient’s deductible or annual out-of-pocket maximum violates the Affordable Care Act and Administrative Procedure Act. Coupons and other discount programs for branded drugs can help consumers with chronic conditions reduce their out-of-pocket costs at the pharmacy counter. But there are concerns that such measures encourage patients to use more expensive medications over less costly treatments, and also contribute to higher drug and health care spending and thus higher premiums.
Potential Impact:
Policies related to copay accumulator programs can promote the use of more expended branded prescription drugs, which may contribute to higher drug spending and higher premiums for all consumers.
12 Major Filings
- REPLY in Support of Plaintiffs' Motion for Summary Judgment and Opposition to Cross-Motion (May 1, 2023)
- SET RESET DEADLINES (Apr 10, 2023)
- AMICUS BRIEF AHIP (Mar 23, 2023)
- Defendants Cross-Motion for Summary Judgment (Mar 16, 2023)
- AMICUS BRIEF Aimed Alliance (Feb 10, 2023)
- AMICUS BRIEF PhRMA (Feb 10, 2023)
- AMICUS BRIEF TrialCard Incorporated (Feb 10, 2023)
- Plaintiff MOTION for Summary Judgement (Feb 2, 2023)
- AMENDED COMPLAINT (Nov 18, 2022)
- RESPONSE re MOTION to Dismiss for Lack of Standing (Nov 14, 2022)
- MOTION to Dismiss for Lack of Standing (Oct 28, 2022)
- COMPLAINT (Aug 30, 2022)